Estimation of C–reactive protein levels in COVID-19 patients A laboratory based observational study

• Published in: International journal of health sciences pp. 10070 - 10075
• Main Authors: Mane, Priyanka M, Mane, Makarand, Patil, S. R.
• Format: Journal Article
• Language: English
• Published: 20.05.2022
• ISSN: 2550-6978; 2550-696X
• DOI: 10.53730/ijhs.v6nS2.7619

COVID-19 is a health emergency due to its high infectiousness and high case fatality in critically ill patients. The pathological and physiological processes and diagnostic methods of COVID-19 are still in the exploratory stage. Clinical monitoring and appropriate treatment strategies are essential to improve case fatality. Aim of study was to detect the level of C- reactive protein in COVID-19 patients, prospective study was conducted in the Department of Microbiology, blood samples of the patient confirmed as COVID -19 positive patients were processed according to the standard laboratory Procedures. CRP was done by the commercially available kit (Rhelax CRP) based on the principle of latex agglutination. There were 13 males and 8 females within the young age group. They had CRP level   2.7524±3.69427 whereas 36 males and 7 females were in moderate grade of Covid 19 infection having CRP values 8.3140±23.01511 and at old age group had males 20 and females 14 with CRP values 6.5729±16.82460. CRP levels increased with disease progression. Conclusion- Higher levels of CRP indicate more severe disease course‐linked to lung injury and worse prognosis.